Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L2AW
|
|||
| Former ID |
DNC002882
|
|||
| Drug Name |
1-Hydroxyamine-2-Isobutylmalonic Acid
|
|||
| Synonyms |
1-HYDROXYAMINE-2-ISOBUTYLMALONIC ACID; (2R)-2-(hydroxycarbamoyl)-4-methylpentanoic acid; AC1O43QE; DB02326
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H13NO4
|
|||
| Canonical SMILES |
CC(C)CC(C(=O)NO)C(=O)O
|
|||
| InChI |
1S/C7H13NO4/c1-4(2)3-5(7(10)11)6(9)8-12/h4-5,12H,3H2,1-2H3,(H,8,9)(H,10,11)/t5-/m1/s1
|
|||
| InChIKey |
CINIOMOBGSHXRK-RXMQYKEDSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Matrix metalloproteinase-8 (MMP-8) | Target Info | Inhibitor | [1] |
| Panther Pathway | Alzheimer disease-presenilin pathway | |||
| Reactome | Collagen degradation | |||
| Degradation of the extracellular matrix | ||||
| Activation of Matrix Metalloproteinases | ||||
| WikiPathways | Activation of Matrix Metalloproteinases | |||
| Matrix Metalloproteinases | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.